UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of January 2026
Commission File Number: 001-41661
Jin Medical International Ltd.
(Exact name of registrant as specified in its charter)
No. 33 Lingxiang Road, Wujin District
Changzhou City, Jiangsu Province
People’s Republic of China
(Address of Principal Executive Office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
Press Release
On January 26, 2026, the Company published a press
release entitled “Jin Medical International Ltd. To Host Management Fireside Chat”, a copy of which is attached hereto
as Exhibit 99.1.
The information in the press release furnished
in Exhibit 99.1 hereto shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liabilities of that section. Furthermore, the information in the press release shall not be deemed
to be incorporated by reference in the filings of the Company under the Securities Act of 1933, as amended, except in the event that the
Company expressly states that such information is to be considered filed under the Exchange Act or incorporates it by specific reference
in such filing.
EXHIBIT INDEX
| Exhibit No. |
|
Description |
| 99.1 |
|
Press Release dated January 26, 2026 |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized.
| |
Jin Medical International Ltd. |
| |
|
|
| Date: January 28, 2026 |
By: |
/s/ Erqi Wang |
| |
|
Erqi Wang |
| |
|
Chief Executive Officer |
3
Exhibit 99.1
Jin Medical International Ltd. To Host Management
Fireside Chat
CHANGZHOU, China, Jan. 26, 2026 /PRNewswire/ -- Jin Medical
International Ltd. (NASDAQ: ZJYL) (“Jin Medical”, and together with all its subsidiaries, the “Company”), a NASDAQ-listed
leading provider of rehabilitation medical equipment in China, announced today that its Chief Executive Officer, together with the Company’s
management team, will host a fireside chat at 8:00 pm EST on February 1, 2026. The discussion will provide insights into the Company’s
recent strategic priorities and long-term growth considerations.
The Company also announced the launch of its updated corporate website
at http://www.jinmed.com, where the fireside chat will be webcast.
About Jin Medical International Ltd.
Founded in 2006 and headquartered at Changzhou, Jiangsu Province of
China, Jin Medical designs, develops, manufactures and markets wheelchairs and living aids products for people with disabilities, elderlies,
and for rehabilitation application. Currently, Jin Medical already operates two manufacturing plants of approximately 230,000 square feet
in the aggregate in Changzhou City and Taizhou City, Jiangsu Province, China. Jin Medical is currently establishing a new facility with
430,000 square feet in Chuzhou, Anhui Province, China. Jin Medical works with more than 40 distributors in China and more than 20 international
distributors. The majority of Jin Medical’s wheelchair products, with more than 30 models, are sold to distributors in Japan and China.
Jin Medical continuously delivers innovative wheelchair products that are both lightweight and ergonomic. For more information, please
visit the Company’s updated website at http://www.jinmed.com.
Forward-Looking Statement
This press release contains forward-looking statements as defined by
the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals,
strategies, future events or performances, and underlying assumptions and other statements that are other than statements of historical
facts. When the Company uses words such as “may”, “will”, “should”, “intend”, “plan”,
“strive”, “believe”, “expect”, “anticipate”, “project”, “estimate,” or similar
expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not
guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s
expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks, including, but not
limited to, the following: the Company’s ability to achieve its goals and strategies, the Company’s future business development and plans
for future business development, including its financial conditions and results of operations, product and service demand and acceptance,
reputation and brand, the impact of competition and pricing, changes in technology, government regulations, import and export restrictions,
fluctuations in general economic and business conditions, and assumptions underlying or related to any of the foregoing and other risks
contained in reports filed by the Company with the U.S. Securities and Exchange Commission (“SEC”). For these reasons, among
others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors
are discussed in the Company’s filings with the SEC, as well as its current reports on Form 6-K and other filings, all of which are available
for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect
events or circumstances that arise after the date hereof.
For more information, please contact:
ir@jinmed.com